"Health Canada never endorses a health product and does not allow its logo to be used in the advertising or packaging of health products," the public advisory said
Obesity is characterized by hyperinsulinemia, increased leptin resistance, systemic inflammation, and altered sex steroid metabolism
Therapeutic potential of semaglutide, a newer GLP-1 receptor agonist, in abating obesity, non-alcoholic steatohepatitis and neurodegenerative diseases: A narrative review
The Phase 2 data showed this directly, and it is one of the clearest safety signals in the entire retatrutide dataset
Patients who combine GLP-1 therapy with dietary changes, regular physical activity, and behavioural strategies typically experience faster and more substantial improvements in both weight and glycaemic control
Hes described compulsive eating through the lens of addictionsomething he understands deeply after years of using food, alcohol, and other substances as a way to cope
